Edition:
United States

Alliance Pharma PLC (ALAPH.L)

ALAPH.L on London Stock Exchange

50.50GBp
23 Jun 2017
Change (% chg)

-0.75 (-1.46%)
Prev Close
51.25
Open
51.00
Day's High
52.00
Day's Low
50.25
Volume
12,851,992
Avg. Vol
1,723,899
52-wk High
56.00
52-wk Low
40.50

ALAPH.L

Chart for ALAPH.L

About

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.... (more)
No analyst recommendations are available for ALAPH.L.

Overall

Beta: --
Market Cap(Mil.): --
Shares Outstanding(Mil.): 14.96
Dividend: --
Yield (%): --

Financials

  ALAPH.L Industry Sector
P/E (TTM): -- 14.09 19.01
EPS (TTM): -- -- --
ROI: -5.16 -6.73 -5.03
ROE: -5.16 -6.18 -4.28

BRIEF-Alliance Pharma FY pre-tax profit up 103 pct to 22.2 mln pounds

* Current year has started well and we look forward to building on our foundations Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Mar 29 2017

BRIEF-Alliance Pharma updates on settlement agreement with Sinclair Pharma

* Reached agreement with Sinclair Pharma for compensation in connection with material reduction of business in Kelo-Stretch™

Mar 21 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.